How the drug services industry found itself prepared for a pandemic
C&EN, 26 September 2021
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
C&EN, 26 September 2021
High Performance, High-Dose Capsule DPI.
Hovione is expanding its scientific know-how and industrial production capabilities on a variety of technologies to widen its ability to provide customized solutions for advanced APIs (aAPI™).
Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally